Message
Meta Text Info
Fetching Project...
Project Description
The Indian pharmaceutical company MSN Group is partnering with Kazakhstan’s KFK Medservice Plus LLPto establish a full-cycle pharmaceutical manufacturing facility in the Almaty Region of Kazakhstan. The project involves the construction of a modern plant under the brand MSN Pharmalab, focusing on the production of solid dosage forms, including tablets and capsules. It aims to localize the entire production chain — from research and development to packaging and distribution. The facility will be export-oriented and is expected to generate over 300 jobs. The project is considered strategically important for Kazakhstan's healthcare industry and is supported by Kazakh Invest through an investment agreement signed in June 2025.
Project Phase:
Engineering Design & Planning
Investment Value:
60 000 000 $
Location:
Almaty, Kazakhstan
Start Date:
7/1/2025
End Date:
Value
Involved Companies
Company:
░░░░░░░░░░░░░░░░░░░░░░░░
Role:
░░░░░░░░░░░░░░░░░░░░░░░
Address:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Phone:
░░░░░░░░░░░░░
Email:
Value
Website:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Other links:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Key Contacts
Name:
░░░░░░░░░░░░░░░░░░
Position:
░░░░░░
Phone:
Value
Email:
░░░░░░░░░░░░░░░░░░
Links:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Name:
Value
Position:
Value
Phone:
Value
Email:
Value
Links:
Value
Company:
░░░░░░░░░░░░░
Role:
░░░░░░░░░░░░
Address:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Phone:
░░░░░░░░░░░░░░░░
Email:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Website:
░░░░░░░░░░░░░░░░░░░░░░░
Other links:
Value
Key Contacts
Name:
░░░░░░░░░░░░░░░░░░
Position:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Phone:
░░░░░░░░░░░░░░
Email:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Links:
Value
Name:
Value
Position:
Value
Phone:
Value
Value
Email:
Links:
Value
Company:
░░░░░░░░░░░░░░░
Role:
░░░░░░░░░░░░░░░░░░░░░░░
Address:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Phone:
Email:
░░░░░░░░░░░░░░░░
Website:
░░░░░░░░░░░░░░░░░░░░
Other links:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Key Contacts
Name:
░░░░░░░░░░░░░░░░
Position:
░░░░░░░░░░░░░
Phone:
Value
░░░░░░░░░░░░░░░░░░░░░░░░░
Email:
Links:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Name:
░░░░░░░░░░░░░░░░
Position:
░░░░░░░░░░░░
Phone:
Value
Email:
░░░░░░░░░░░░░░░░░░░░░░░░
Links:
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
Company:
VALUE
Role:
Value
Address:
Value
Phone:
Value
Email:
Value
Website:
Value
Other links:
Value
Key Contacts
Name:
Value
Position:
Value
Value
Phone:
Value
Email:
Links:
Value
Name:
Value
Position:
Value
Phone:
Value
Email:
Value
Links:
Value
Company:
VALUE
Role:
Value
Address:
Value
Phone:
Value
Email:
Value
Website:
Value
Other links:
Value
Key Contacts
Name:
Value
Position:
Value
Value
Phone:
Email:
Value
Links:
Value
Name:
Value
Position:
Value
Phone:
Value
Value
Email:
Links:
Value
Other important details
· The plant will focus on export to Central Asia, CIS, and European markets.
· Includes R&D component for formulation and process development.
· Supported under Kazakhstan’s investment incentives program.
· Project aligns with Kazakhstan’s healthcare localization and pharmaceutical security goals.
· MSME technology will be transferred and adapted for local GMP-compliant production.
Sources
Publication/Revision Date:
7/15/2025